MDXG
MiMedx Group, Inc.
Price Chart
Latest Quote
$3.83
+0.10 (+2.68%)
Current Price
| Previous Close | $3.73 |
| Open | $3.71 |
| Day High | $3.88 |
| Day Low | $3.71 |
| Volume | 780,903 |
Stock Information
| Shares Outstanding | 148.95M |
| Total Debt | $17.59M |
| Cash Equivalents | $159.77M |
| Revenue | $389.42M |
| Net Income | $30.70M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $570.46M |
| P/E Ratio | 19.15 |
| EPS (TTM) | $0.20 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $428.28M |
| Sales | $389.42M |
| Income | $30.70M |
| Book/sh | $1.73 |
| Cash/sh | $1.07 |
| Employees | 808 |
Financial Ratios
| Quick Ratio | 4.62 |
| Current Ratio | 5.39 |
| Debt/Eq | 7.24 |
Returns & Margins
| ROA | 8.54% |
| ROE | 13.77% |
| Gross Margin | 81.04% |
| Operating Margin | -27.21% |
| Profit Margin | 7.88% |
Ownership
| Insider Ownership | 2.11% |
| Institutional Ownership | 76.90% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 31.27 |
| PEG | 2.88 |
| P/S | 1.46 |
| P/B | 2.21 |
Analyst Data
| Recommendation | none |
| Target Price | $6.50 |
Technical Indicators
| SMA20 | $3.67 |
| SMA50 | $3.59 |
| SMA200 | $5.43 |
| RSI | 62.50 |
| ATR | 0.1361 |
| Shares Float | 118.02M |
| Short Float | 6.40% |
| Short Ratio | 4.15 |
| Volatility | 1.46 |
| Rel Volume | 0.62 |
Performance History
| Week | +3.51% |
| Month | +5.80% |
| Quarter | -7.26% |
| 6 Months | -45.67% |
| YTD | -40.90% |
| Year | -35.52% |
| 3 Years | -33.16% |
| 5 Years | -66.34% |
| 10 Years | -46.13% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $3.83 | 783,585 |
| 2026-06-23 | $3.73 | 833,300 |
| 2026-06-22 | $3.67 | 1,111,100 |
| 2026-06-18 | $3.67 | 2,130,600 |
| 2026-06-17 | $3.61 | 998,800 |
| 2026-06-16 | $3.70 | 1,310,100 |
| 2026-06-15 | $3.68 | 1,077,200 |
| 2026-06-12 | $3.60 | 947,100 |
| 2026-06-11 | $3.69 | 1,122,200 |
| 2026-06-10 | $3.64 | 968,000 |
| 2026-06-09 | $3.71 | 1,134,600 |
| 2026-06-08 | $3.70 | 1,088,800 |
| 2026-06-05 | $3.74 | 1,156,700 |
| 2026-06-04 | $3.78 | 1,328,800 |
| 2026-06-03 | $3.61 | 1,297,600 |
| 2026-06-02 | $3.57 | 1,173,800 |
| 2026-06-01 | $3.58 | 1,396,500 |
| 2026-05-29 | $3.68 | 3,291,800 |
| 2026-05-28 | $3.67 | 1,188,700 |
| 2026-05-27 | $3.61 | 756,400 |
| 2026-05-26 | $3.67 | 2,190,900 |
About MiMedx Group, Inc.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.
đ° Latest News
MiMedx Group (MDXG) Stock Faces Mixed Analyst Target Changes After Guidance Cut
Simply Wall St. âĸ 2026-06-20T23:07:36Z
How The MiMedx Group (MDXG) Story Is Shifting As Analysts Rework Price Targets
Simply Wall St. âĸ 2026-06-06T19:10:25Z
Is the Options Market Predicting a Spike in MiMedx Group Stock?
Zacks âĸ 2026-05-11T18:36:00Z
Some May Be Optimistic About MiMedx Group's (NASDAQ:MDXG) Earnings
Simply Wall St. âĸ 2026-05-07T11:01:48Z
How Reimbursement Shifts Are Rewriting The MiMedx Group (MDXG) Investment Narrative
Simply Wall St. âĸ 2026-05-05T17:10:40Z
MiMedx Group, Inc. (NASDAQ:MDXG) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall St. âĸ 2026-05-03T13:30:33Z
MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds
Insider Monkey âĸ 2026-05-01T09:22:11Z
MiMedx Group Inc (MDXG) Q1 2026 Earnings Call Highlights: Navigating Growth and Challenges
GuruFocus.com âĸ 2026-04-30T07:16:22ZMiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-04-29T22:40:09Z
MiMedx Group Q1 Earnings Call Highlights
MarketBeat âĸ 2026-04-29T21:50:18Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $58,571,000 | $54,797,000 | $51,969,000 | $44,971,000 |
| Cost Of Revenue | $73,013,000 | $60,073,000 | $54,634,000 | $48,316,000 |
| Total Revenue | $418,630,000 | $348,879,000 | $321,477,000 | $267,841,000 |
| Operating Revenue | $418,630,000 | $348,879,000 | $321,477,000 | $267,841,000 |
| Expenses | ||||
| Total Expenses | $354,743,000 | $289,568,000 | $284,361,000 | $282,568,000 |
| Other Income Expense | $-558,000 | $-1,011,000 | $-26,000 | $-4,000 |
| Other Non Operating Income Expenses | $-558,000 | $-565,000 | $-26,000 | $-4,000 |
| Net Non Operating Interest Income Expense | $2,933,000 | $-1,006,000 | $-6,457,000 | $-5,016,000 |
| Total Other Finance Cost | $-2,933,000 | $1,006,000 | $6,457,000 | - |
| Operating Expense | $281,730,000 | $229,495,000 | $229,727,000 | $234,252,000 |
| Interest Expense | - | $1,006,000 | $6,457,000 | $5,016,000 |
| Interest Expense Non Operating | - | $1,006,000 | $6,457,000 | $5,016,000 |
| Other Operating Expenses | - | $-8,698,000 | $5,176,000 | $12,177,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $48,578,000 | $41,998,000 | $67,439,000 | $-19,953,000 |
| Net Interest Income | $2,933,000 | $-1,006,000 | $-6,457,000 | $-5,016,000 |
| Normalized Income | $48,578,000 | $42,324,918 | $67,439,000 | $-19,953,000 |
| Net Income From Continuing And Discontinued Operation | $48,578,000 | $42,419,000 | $58,228,000 | $-30,197,000 |
| Total Operating Income As Reported | $63,887,000 | $58,865,000 | $37,116,000 | $-14,727,000 |
| Net Income Common Stockholders | $48,578,000 | $42,419,000 | $46,585,000 | $-36,777,000 |
| Net Income | $48,578,000 | $42,419,000 | $58,228,000 | $-30,197,000 |
| Net Income Including Noncontrolling Interests | $48,578,000 | $42,419,000 | $58,228,000 | $-30,197,000 |
| Net Income Discontinuous Operations | $0 | $421,000 | $-9,211,000 | $-10,244,000 |
| Net Income Continuous Operations | $48,578,000 | $41,998,000 | $67,439,000 | $-19,953,000 |
| Pretax Income | $66,262,000 | $57,294,000 | $30,633,000 | $-19,747,000 |
| Special Income Charges | $0 | $-446,000 | $0 | $0 |
| Operating Income | $63,887,000 | $59,311,000 | $37,116,000 | $-14,727,000 |
| Depreciation Amortization Depletion Income Statement | $439,000 | $765,000 | $762,000 | $701,000 |
| Depreciation And Amortization In Income Statement | $439,000 | $765,000 | $762,000 | $701,000 |
| Amortization Of Intangibles Income Statement | $439,000 | $765,000 | $762,000 | $701,000 |
| Gross Profit | $345,617,000 | $288,806,000 | $266,843,000 | $219,525,000 |
| Per Share | ||||
| Diluted EPS | $0.32 | $0.28 | $0.37 | $-0.33 |
| Basic EPS | $0.33 | $0.29 | $0.40 | $-0.33 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-119,082 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $78,768,000 | $65,798,000 | $40,543,000 | $-10,685,000 |
| Total Unusual Items | $0 | $-446,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $0 | $-446,000 | $0 | $0 |
| Reconciled Depreciation | $14,881,000 | $6,041,000 | $3,427,000 | $4,046,000 |
| EBITDA (Bullshit earnings) | $78,768,000 | $65,352,000 | $40,543,000 | $-10,685,000 |
| EBIT | $63,887,000 | $59,311,000 | $37,116,000 | $-14,731,000 |
| Diluted Average Shares | $149,724,507 | $149,049,197 | $145,962,462 | $112,909,266 |
| Basic Average Shares | $147,793,069 | $146,979,354 | $116,495,810 | $112,909,266 |
| Diluted NI Availto Com Stockholders | $48,578,000 | $42,419,000 | $46,585,000 | $-36,777,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $4,890,000 | $0 |
| Tax Provision | $17,684,000 | $15,296,000 | $-36,806,000 | $206,000 |
| Impairment Of Capital Assets | $0 | $446,000 | $0 | $0 |
| Amortization | $439,000 | $765,000 | $762,000 | $701,000 |
| Research And Development | $15,097,000 | $12,341,000 | $12,665,000 | $12,701,000 |
| Selling General And Administration | $266,194,000 | $225,087,000 | $211,124,000 | $208,673,000 |
| Preferred Stock Dividends | - | - | $6,753,000 | $6,580,000 |
Fetched: 2026-06-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $222,949,000 | $162,040,000 | $118,019,000 | $-43,281,000 |
| Total Assets | $342,653,000 | $263,915,000 | $239,047,000 | $171,430,000 |
| Total Non Current Assets | $65,182,000 | $72,029,000 | $74,786,000 | $37,232,000 |
| Other Non Current Assets | $7,274,000 | $6,712,000 | $205,000 | $683,000 |
| Non Current Deferred Assets | $19,596,000 | $28,306,000 | $40,777,000 | $0 |
| Non Current Deferred Taxes Assets | $19,596,000 | $28,306,000 | $40,777,000 | $0 |
| Goodwill And Other Intangible Assets | $33,599,000 | $31,067,000 | $24,698,000 | $25,293,000 |
| Other Intangible Assets | $14,158,000 | $11,626,000 | $5,257,000 | $5,852,000 |
| Current Assets | $277,471,000 | $191,886,000 | $164,261,000 | $134,198,000 |
| Other Current Assets | $10,303,000 | $7,835,000 | $1,745,000 | $3,335,000 |
| Inventory | $25,340,000 | $23,807,000 | $21,021,000 | $13,183,000 |
| Receivables | $75,707,000 | $55,828,000 | $53,871,000 | $43,084,000 |
| Accounts Receivable | $75,707,000 | $55,828,000 | $53,871,000 | $43,084,000 |
| Allowance For Doubtful Accounts Receivable | $-8,703,000 | $-3,132,000 | $-3,144,000 | $-3,783,000 |
| Gross Accounts Receivable | $84,410,000 | $58,960,000 | $57,015,000 | $46,867,000 |
| Cash Cash Equivalents And Short Term Investments | $166,121,000 | $104,416,000 | $82,000,000 | $65,950,000 |
| Cash And Cash Equivalents | $166,121,000 | $104,416,000 | $82,000,000 | $65,950,000 |
| Prepaid Assets | - | $5,018,000 | $5,624,000 | $7,315,000 |
| Assets Held For Sale Current | - | - | $0 | $1,331,000 |
| Taxes Receivable | - | - | - | $704,000 |
| Debt | ||||
| Total Debt | $17,967,000 | $18,830,000 | $49,099,000 | $48,594,000 |
| Long Term Debt And Capital Lease Obligation | $16,467,000 | $17,830,000 | $48,099,000 | $48,594,000 |
| Long Term Debt | $16,467,000 | $17,830,000 | $48,099,000 | $48,594,000 |
| Current Debt And Capital Lease Obligation | $1,500,000 | $1,000,000 | $1,000,000 | - |
| Current Debt | $1,500,000 | $1,000,000 | $1,000,000 | - |
| Other Current Borrowings | $1,500,000 | $1,000,000 | $1,000,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $86,105,000 | $70,808,000 | $96,330,000 | $189,418,000 |
| Total Non Current Liabilities Net Minority Interest | $21,839,000 | $25,213,000 | $50,322,000 | $145,861,000 |
| Other Non Current Liabilities | $5,372,000 | $7,383,000 | $2,223,000 | $4,773,000 |
| Current Liabilities | $64,266,000 | $45,595,000 | $46,008,000 | $43,557,000 |
| Other Current Liabilities | $5,790,000 | $4,507,000 | $4,246,000 | $3,313,000 |
| Payables And Accrued Expenses | $25,911,000 | $16,421,000 | $18,409,000 | $19,388,000 |
| Payables | $14,528,000 | $7,409,000 | $9,048,000 | $8,454,000 |
| Accounts Payable | $14,528,000 | $7,409,000 | $9,048,000 | $8,454,000 |
| Other Payable | - | $1,421,000 | - | - |
| Equity | ||||
| Common Stock Equity | $256,548,000 | $193,107,000 | $142,717,000 | $-17,988,000 |
| Total Equity Gross Minority Interest | $256,548,000 | $193,107,000 | $142,717,000 | $-17,988,000 |
| Stockholders Equity | $256,548,000 | $193,107,000 | $142,717,000 | $-17,988,000 |
| Retained Earnings | $-42,681,000 | $-91,259,000 | $-133,678,000 | $-191,906,000 |
| Preferred Securities Outside Stock Equity | - | - | $0 | $92,494,000 |
| Preferred Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $148,093,920 | $146,932,032 | $146,227,639 | $113,705,447 |
| Share Issued | $148,093,920 | $146,932,032 | $146,227,639 | $113,705,447 |
| Tangible Book Value | $222,949,000 | $162,040,000 | $118,019,000 | $-43,281,000 |
| Invested Capital | $274,515,000 | $211,937,000 | $191,816,000 | $30,606,000 |
| Working Capital | $213,205,000 | $146,291,000 | $118,253,000 | $90,641,000 |
| Total Capitalization | $273,015,000 | $210,937,000 | $190,816,000 | $30,606,000 |
| Additional Paid In Capital | $299,081,000 | $284,219,000 | $276,249,000 | $173,804,000 |
| Capital Stock | $148,000 | $147,000 | $146,000 | $114,000 |
| Common Stock | $148,000 | $147,000 | $146,000 | $114,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $31,065,000 | $23,667,000 | $22,353,000 | $20,856,000 |
| Current Accrued Expenses | $11,383,000 | $9,012,000 | $9,361,000 | $10,934,000 |
| Goodwill | $19,441,000 | $19,441,000 | $19,441,000 | $19,441,000 |
| Net PPE | $4,713,000 | $5,944,000 | $9,106,000 | $11,256,000 |
| Accumulated Depreciation | $-23,498,000 | $-21,322,000 | $-20,028,000 | $-35,927,000 |
| Gross PPE | $28,211,000 | $27,266,000 | $29,134,000 | $47,183,000 |
| Leases | $8,977,000 | $8,213,000 | $8,141,000 | $9,190,000 |
| Construction In Progress | $612,000 | $686,000 | $1,791,000 | $1,983,000 |
| Other Properties | $16,614,000 | $16,416,000 | $17,213,000 | $20,994,000 |
| Machinery Furniture Equipment | $2,008,000 | $1,951,000 | $1,989,000 | $15,016,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $15,453,000 | $14,217,000 | $11,675,000 | $5,518,000 |
| Work In Process | $8,666,000 | $8,580,000 | $8,521,000 | $6,855,000 |
| Raw Materials | $1,221,000 | $1,010,000 | $825,000 | $810,000 |
| Treasury Shares Number | - | - | $0 | - |
| Treasury Stock | - | - | $0 | $0 |
| Preferred Shares Number | - | - | - | $100,000 |
| Preferred Stock | - | - | - | $0 |
Fetched: 2026-06-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $72,970,000 | $64,515,000 | $24,788,000 | $-19,407,000 |
| Operating Activities | ||||
| Operating Cash Flow | $74,003,000 | $66,198,000 | $26,775,000 | $-17,893,000 |
| Cash From Discontinued Operating Activities | $0 | $-930,000 | $-8,162,000 | $-9,921,000 |
| Cash Flow From Continuing Operating Activities | $74,003,000 | $67,128,000 | $34,937,000 | $-7,972,000 |
| Operating Gains Losses | - | $1,401,000 | $15,000 | $-17,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,033,000 | $-1,683,000 | $-1,987,000 | $-1,514,000 |
| Investing Cash Flow | $-6,886,000 | $-9,583,000 | $-2,155,000 | $-2,660,000 |
| Cash Flow From Continuing Investing Activities | $-6,886,000 | $-9,583,000 | $-2,155,000 | $-2,660,000 |
| Net Other Investing Changes | $-2,089,000 | $-38,000 | $-168,000 | $-1,146,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-3,118,000 | $-2,641,000 | $-9,515,000 | $-1,190,000 |
| Financing Cash Flow | $-5,412,000 | $-34,199,000 | $-8,570,000 | $-580,000 |
| Cash Flow From Continuing Financing Activities | $-5,412,000 | $-34,199,000 | $-8,570,000 | $-580,000 |
| Net Other Financing Charges | $-1,294,000 | $-1,238,000 | $-52,000 | $-41,000 |
| Net Preferred Stock Issuance | $0 | $0 | $-9,515,000 | $0 |
| Net Common Stock Issuance | $-3,118,000 | $-2,641,000 | $0 | $-1,190,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-1,000,000 | $-81,500,000 | $0 | $0 |
| Issuance Of Debt | $0 | $49,783,000 | $0 | $0 |
| End Cash Position | $166,121,000 | $104,416,000 | $82,000,000 | $65,950,000 |
| Beginning Cash Position | $104,416,000 | $82,000,000 | $65,950,000 | $87,083,000 |
| Changes In Cash | $61,705,000 | $22,416,000 | $16,050,000 | $-21,133,000 |
| Proceeds From Stock Option Exercised | $0 | $1,397,000 | $997,000 | $651,000 |
| Preferred Stock Payments | $0 | $0 | $-9,515,000 | $0 |
| Common Stock Payments | $-3,118,000 | $-2,641,000 | $0 | $-1,190,000 |
| Net Issuance Payments Of Debt | $-1,000,000 | $-31,717,000 | $0 | $0 |
| Net Long Term Debt Issuance | $-1,000,000 | $-31,717,000 | $0 | $0 |
| Long Term Debt Payments | $-1,000,000 | $-81,500,000 | $0 | $0 |
| Long Term Debt Issuance | $0 | $49,783,000 | $0 | $0 |
| Net Business Purchase And Sale | $-3,764,000 | $-7,862,000 | $0 | $0 |
| Purchase Of Business | $-3,764,000 | $-7,862,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-1,033,000 | $-1,683,000 | $-1,987,000 | $-1,514,000 |
| Purchase Of PPE | $-1,033,000 | $-1,683,000 | $-1,987,000 | $-1,514,000 |
| Change In Working Capital | $-22,980,000 | $-5,434,000 | $-18,416,000 | $-8,014,000 |
| Change In Other Working Capital | $289,000 | $-870,000 | $-497,000 | $-258,000 |
| Change In Other Current Assets | $-8,818,000 | $-352,000 | $1,252,000 | $-333,000 |
| Change In Payables And Accrued Expense | $13,476,000 | $697,000 | $904,000 | $1,346,000 |
| Change In Accrued Expense | $11,357,000 | $2,107,000 | $121,000 | $507,000 |
| Change In Payable | $2,119,000 | $-1,410,000 | $783,000 | $839,000 |
| Change In Account Payable | $2,119,000 | $-1,410,000 | $783,000 | $839,000 |
| Change In Inventory | $-1,533,000 | $-2,357,000 | $-7,838,000 | $-1,794,000 |
| Change In Receivables | $-26,394,000 | $-2,552,000 | $-12,237,000 | $-5,937,000 |
| Other Non Cash Items | $1,903,000 | $-6,878,000 | $1,881,000 | $1,801,000 |
| Stock Based Compensation | $16,396,000 | $16,933,000 | $16,959,000 | $11,328,000 |
| Provisionand Write Offof Assets | $6,515,000 | $595,000 | $1,449,000 | $2,820,000 |
| Deferred Tax | $8,710,000 | $12,472,000 | $-37,802,000 | $0 |
| Deferred Income Tax | $8,710,000 | $12,472,000 | $-37,802,000 | $0 |
| Depreciation Amortization Depletion | $14,881,000 | $6,041,000 | $3,427,000 | $4,046,000 |
| Depreciation And Amortization | $14,881,000 | $6,041,000 | $3,427,000 | $4,046,000 |
| Net Income From Continuing Operations | $48,578,000 | $41,998,000 | $67,439,000 | $-19,953,000 |
| Interest Paid Supplemental Data | - | $2,698,000 | $6,034,000 | $4,569,000 |
| Income Tax Paid Supplemental Data | - | $3,247,000 | - | $181,000 |
| Change In Prepaid Assets | - | $606,000 | $-283,000 | $-1,371,000 |
| Amortization Cash Flow | - | $3,762,000 | $762,000 | $701,000 |
| Amortization Of Intangibles | - | $3,762,000 | $762,000 | $701,000 |
| Depreciation | - | $2,279,000 | $2,665,000 | $3,345,000 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-1,000,000 |
| Purchase Of Intangibles | - | - | $0 | $-1,000,000 |
| Sale Of PPE | - | - | $0 | $24,000 |
| Change In Other Current Liabilities | - | - | $-497,000 | $38,000 |
| Changes In Account Receivables | - | - | $-12,237,000 | $-5,550,000 |
| Asset Impairment Charge | - | - | $1,449,000 | $2,820,000 |
| Gain Loss On Sale Of PPE | - | - | $15,000 | $-17,000 |
Fetched: 2026-06-25